Nature_Reviews_Drug_Discovery

<i>Nature Reviews Drug Discovery</i>

Nature Reviews Drug Discovery

Academic journal

Nature Reviews Drug Discovery is a monthly peer-reviewed review journal published by Nature Portfolio. It was established in 2002[1] and covers drug discovery and development. The editor-in-chief is Peter Kirkpatrick.[2] According to the Journal Citation Reports, the journal has a 2021 impact factor of 112.288, ranking it 1st out of 158 journals in the category "Biotechnology & Applied Microbiology"[3] and 1st out of 279 journals in the category "Pharmacology & Pharmacy".[4]

Quick Facts Discipline, Language ...

Reviews are commissioned to specialists and supplemented with glossary explanations for non-specialist readers and illustrated with figures drawn by Nature's in-house art editors. Besides reviews, the journal publishes analysis articles based on existing datasets (e.g. metaanalysis), progress articles that focus on outstanding issues, and perspective articles—typically opinions or historical pieces.[5]

See also

References

  1. [1]
    "Displaying Record for Publication: Nature Reviews Drug Discovery". CASSI. Chemical Abstracts Service. Retrieved 2022-08-09.
  2. [2]
    "About the Editors". nature.com. Springer Nature. Retrieved 2022-08-09.
  3. [3]
    "Journals Ranked by Impact: Biotechnology & Applied Microbiology". 2021 Journal Citation Reports. Web of Science (Science ed.). Clarivate. 2022.
  4. [4]
    "Journals Ranked by Impact: Pharmacology & Pharmacy". 2021 Journal Citation Reports. Web of Science (Science ed.). Clarivate. 2022.
  5. [5]
    Guide : Information : Nature Reviews Drug Discovery. Nature.com. Retrieved on 2011-06-29.


Stub icon 1 Stub icon 2

This article about a pharmacology journal is a stub. You can help Wikipedia by expanding it.

See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.
Share this article:

This article uses material from the Wikipedia article Nature_Reviews_Drug_Discovery, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.